glp-1 for addiction treatment The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders GLP-1 and Addiction: Clinical Trials

Your right to access a compounded medication during the shortage was protected

We thank the commenters for their feedback related to our proposal for CPT code 0817T and we agree with one of the comments that it is appropriately placed in APC 5464 based on resource cost and clinical homogeneity to other similar codes in that APC

However, human clinical trials are scarce

Copycat products and inadequate oversight: We already have a troubling market of compounded products, "research" peptides, microdosing plans, longevity packages, and cosmetic weight-loss programs with inadequate medical supervision

It is not recommended in pregnancy, and is not established for those under 18 or, generally, for those aged 75 and over